Cite Filings / ADAPY / 0001104659-23-066058

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

Adaptimmune Therapeutics PLC Filed 2023-05-30 Acc 0001104659-23-066058

Documents 1

425 Prospectus/Communication re Business Combination , tm2317177d4_425.htm

Around this filing

2023-06-01 4 Director acquired 611,224 shares (grant or award)
2023-06-01 3 Initial Statement of Ownership
2023-06-01 3 Initial Statement of Ownership
2023-06-01 3 Initial Statement of Ownership
2023-05-30 425 Prospectus/Communication re Business Combination
2023-05-30 8-K Shareholder vote results
2023-05-22 425 Prospectus/Communication re Business Combination

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2317177d4_425.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…